These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14473694)

  • 1. [Treatment of infantile visceral leishmaniasis with solusurmin according to material of the parasitological department of the Tashkent City Sanitary-Epidemiological Station].
    MIKHAILOV VG; STARTSEVA MA
    Med Parazitol (Mosk); 1961; 30():563-7. PubMed ID: 14473694
    [No Abstract]   [Full Text] [Related]  

  • 2. [Micromethod in determination of antimony in blood and urine in visceral leishmaniasis during solusurmin therapy].
    LAPIN LN
    Vopr Med Khim; 1956; 2(4):309-15. PubMed ID: 13392574
    [No Abstract]   [Full Text] [Related]  

  • 3. [METABOLISM OF ANTIMONY IN CHILDREN WITH VISCERAL LEISHMANIASIS TREATED WITH SOLUSURMIN. II].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1964; 33():438-43. PubMed ID: 14250146
    [No Abstract]   [Full Text] [Related]  

  • 4. [The level of antimony in dogs with visceral leishmaniasis treated with solusurmin].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1962; 31():723-7. PubMed ID: 13945955
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of visceral leishmaniasis with solusurmin in children].
    KARAKHODZHAEV BKh
    Pediatriia; 1953; 4():60-1. PubMed ID: 13088230
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis.
    Badaro R; Johnson WD
    J Infect Dis; 1993 Mar; 167 Suppl 1():S13-7. PubMed ID: 8433014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony.
    Harms G; Zwingenberger K; Sandkamp B; Omena S; Pedrosa C; Richter J; Rosenkaimer F; Feldmeier H; Bienzle U
    J Interferon Res; 1993 Feb; 13(1):39-41. PubMed ID: 8454909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The current status of the problem of visceral leishmaniasis].
    MIRZOIAN NA
    Med Zh Uzb; 1961 Aug; 8():54-9. PubMed ID: 14474513
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antimony resistance in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1957; 26(3):277-80. PubMed ID: 13482777
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the treatment of visceral leishmaniasis in dogs with massive doses of solusurmin].
    Fuzailov IuM; Ibragimov II
    Med Parazitol (Mosk); 1969; 38(5):615-6. PubMed ID: 5371784
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of recombinant gamma interferon associated with pentavalent antimony in therapy for visceral leishmaniasis.
    Badaro R
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():376-7. PubMed ID: 3151000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives].
    WILDE H; DI CARLO FC; PESSAT OA
    Rev Med Cordoba; 1956 Sep; 44():319-31. PubMed ID: 13420979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antimony therapy in visceral leishmaniasis].
    SAN ANTONIO ALVAREZ J
    Farmacoter Actual; 1945 Feb; 2(2):109-22. PubMed ID: 20994166
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives: personal observation].
    DI CARLO FC; PESSAT OA; WILDE H
    Dia Med; 1956 Nov; 28(84):2629-31; passim. PubMed ID: 13397380
    [No Abstract]   [Full Text] [Related]  

  • 16. [Azotemic nephritis during antimony therapy of a case of infantile visceral leishmaniasis].
    CHARLAS R; BENABADJI A
    Maroc Med; 1962 Dec; 41():1180-2. PubMed ID: 14020224
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxic nephritis during the course of antimony treatment of kala-azar].
    BOUDIN G; PEPIN B; MORIN
    Concours Med; 1957 Jun; 79(24):2927-9. PubMed ID: 13447377
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.
    Badaro R; Falcoff E; Badaro FS; Carvalho EM; Pedral-Sampaio D; Barral A; Carvalho JS; Barral-Netto M; Brandely M; Silva L
    N Engl J Med; 1990 Jan; 322(1):16-21. PubMed ID: 2104665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of effectiveness of antimony preparations in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1954; 23(2):161-4. PubMed ID: 13175906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Case of visceral leishmaniasis in adult treated with N-methylglucamine antimony].
    NAPOLITANO F
    G Med Mil; 1952; 102(6):521-7. PubMed ID: 13034080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.